SCHEMBL21153247

SCHEMBL21153247

CN(C)c1ccc(/N=N/c2ccc(C(=O)NCc3cc(F)c(OCC(=O)C(CCCCN)NC(=O)c4cccc(N)c4)c(F)c3)cc2)cc1

nearest known ligand 0.83

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CTSK P43235 2/20 0.41
CTSH P09668 1/20 0.41
CTSL P07711 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21153255 1.00 CTSK (0.41) CTSKCTSHCTSL
SCHEMBL21153262 0.93 PRSS1 (0.41) CTSKCTSH
SCHEMBL21153253 0.93 PRSS1 (0.41) CTSKCTSH
SCHEMBL19982922 0.91 CTSK (0.39) CTSKCTSHCTSL
SCHEMBL19982920 0.91 CTSK (0.39) CTSKCTSHCTSL
SCHEMBL21113155 0.91 CTSK (0.39) CTSKCTSHCTSL
SCHEMBL19983033 0.84 PRSS1 (0.39)
SCHEMBL19982971 0.84 PRSS1 (0.39)
SCHEMBL19972757 0.83 CTSK (0.40) CTSKCTSH
SCHEMBL19982989 0.83 CTSK (0.40) CTSKCTSH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230142714-A1 KETONE INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2023-05-11 US disclosed
US-11325884-B2 Ketone inhibitors of lysine gingipain Cortexyme, Inc. (US) 2022-05-10 US disclosed
US-20210053908-A1 KETONE INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2021-02-25 US disclosed
US-10730826-B2 Ketone inhibitors of lysine gingipain Cortexyme, Inc. (US) 2020-08-04 US disclosed
US-20190210960-A1 KETONE INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210053908-A1 KETONE INHIBITORS OF LYSINE GINGIPAIN PHYKPL, ENPEP, PREP CTSK 379/4885CTSH 874/4885CTSL 264/4885
US-20230142714-A1 KETONE INHIBITORS OF LYSINE GINGIPAIN PHYKPL, ENPEP, PREP CTSK 379/4885CTSH 874/4885CTSL 264/4885
US-10730826-B2 Ketone inhibitors of lysine gingipain PHYKPL, ENPEP, PREP CTSK 379/4885CTSH 874/4885CTSL 264/4885
US-20190210960-A1 KETONE INHIBITORS OF LYSINE GINGIPAIN PHYKPL, ENPEP, PREP CTSK 379/4885CTSH 874/4885CTSL 264/4885
US-11325884-B2 Ketone inhibitors of lysine gingipain PHYKPL, ENPEP, PREP CTSK 379/4885CTSH 874/4885CTSL 264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.